525 related articles for article (PubMed ID: 32244448)
1. Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
Dhalla NS; Shah AK; Tappia PS
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244448
[TBL] [Abstract][Full Text] [Related]
2. Subcellular remodeling and heart dysfunction in chronic diabetes.
Dhalla NS; Liu X; Panagia V; Takeda N
Cardiovasc Res; 1998 Nov; 40(2):239-47. PubMed ID: 9893715
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of subcellular remodeling in heart failure due to diabetes.
Dhalla NS; Takeda N; Rodriguez-Leyva D; Elimban V
Heart Fail Rev; 2014 Jan; 19(1):87-99. PubMed ID: 23436108
[TBL] [Abstract][Full Text] [Related]
4. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
[TBL] [Abstract][Full Text] [Related]
5. Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy.
Dhalla NS; Rangi S; Zieroth S; Xu YJ
Exp Clin Cardiol; 2012 Sep; 17(3):115-20. PubMed ID: 23620698
[TBL] [Abstract][Full Text] [Related]
6. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
7. Role of catecholamines in the pathogenesis of diabetic cardiomyopathy
Dhalla NS; Ganguly PK; Bhullar SK; Tappia PS
Can J Physiol Pharmacol; 2019 Sep; 97(9):815-819. PubMed ID: 30913398
[TBL] [Abstract][Full Text] [Related]
8. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
Babick AP; Dhalla NS
Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
[TBL] [Abstract][Full Text] [Related]
9. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
Khan S; Ahmad SS; Kamal MA
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
[TBL] [Abstract][Full Text] [Related]
10. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
Mahmoud AM
Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress: a key contributor to diabetic cardiomyopathy.
Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
[TBL] [Abstract][Full Text] [Related]
12. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G; Hill MA; Sowers JR
Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy.
Zamora M; Villena JA
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212580
[TBL] [Abstract][Full Text] [Related]
14. Sequence of alterations in subcellular organelles during the development of heart dysfunction in diabetes.
Takeda N; Dixon IM; Hata T; Elimban V; Shah KR; Dhalla NS
Diabetes Res Clin Pract; 1996 Feb; 30 Suppl():113-22. PubMed ID: 8964185
[TBL] [Abstract][Full Text] [Related]
15. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.
Thomas CM; Yong QC; Rosa RM; Seqqat R; Gopal S; Casarini DE; Jones WK; Gupta S; Baker KM; Kumar R
Am J Physiol Heart Circ Physiol; 2014 Oct; 307(7):H1036-45. PubMed ID: 25085967
[TBL] [Abstract][Full Text] [Related]
17. Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease.
Dhalla NS; Saini HK; Tappia PS; Sethi R; Mengi SA; Gupta SK
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):238-50. PubMed ID: 17413299
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Dysfunction and Diabetic Cardiomyopathy.
Wang M; Li Y; Li S; Lv J
Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes.
Liu X; Suzuki H; Sethi R; Tappia PS; Takeda N; Dhalla NS
Ann N Y Acad Sci; 2006 Nov; 1084():141-54. PubMed ID: 17151298
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Jia G; DeMarco VG; Sowers JR
Nat Rev Endocrinol; 2016 Mar; 12(3):144-53. PubMed ID: 26678809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
